Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Volume

the recerts are important, but reaching "an optimum value" directly correlates to PTSC's rights and strategy to enforce the MMP.

This is why the negotiation and litigation with TPL and the ability of the BoD to devise additonal licensing options is critical now. This is why many shareholders have questioned the BoD's "qualifications and experience" because of all the past failures. If they lose on this one, you can stop looking for those "dividend payments".

Share
New Message
Please login to post a reply